Aerie Pharmaceuticals shares owned by Benchmark Capital Advisors
Quarter-by-quarter ownership of Aerie Pharmaceuticals shares owned by Benchmark Capital Advisors
from 13F filings
Historical chart of Benchmark Capital Advisors investment in Aerie Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aerie Pharmaceuticals held by Benchmark Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerie Pharmaceuticals by Benchmark Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2018-12-31 | $902k | 25k | 36.08 |
| 2018-09-30 | $2.1M | 34k | 61.55 |
| 2018-06-30 | $2.4M | 35k | 67.54 |
| 2018-03-31 | $1.6M | 30k | 54.26 |
| 2017-12-31 | $1.8M | 30k | 59.76 |
| 2017-09-30 | $1.4M | 29k | 48.61 |
| 2017-06-30 | $704k | 13k | 52.54 |
| 2017-03-31 | $2.2M | 49k | 45.35 |
| 2016-12-31 | $2.3M | 61k | 37.86 |
| 2016-09-30 | $2.4M | 63k | 37.74 |
| 2016-06-30 | $963k | 55k | 17.61 |
| 2016-03-31 | $614k | 51k | 12.16 |
| 2015-12-31 | $1.4M | 56k | 24.35 |
| 2015-09-30 | $999k | 56k | 17.74 |
| 2015-06-30 | $978k | 55k | 17.65 |
| 2015-03-31 | $555k | 18k | 31.36 |
| 2014-12-31 | $1.4M | 49k | 29.18 |
| 2014-09-30 | $972k | 47k | 20.68 |
More positions owned by Benchmark Capital Advisors
View all positions for Benchmark Capital Advisors